alpha-Hydroxylation pathway in the in vitro metabolism of carcinogenic nitrosamines: N-nitrosodimethylamine and N-nitroso-N-methylaniline. 1981

M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda

Evolution of 15N2-labeled molecular nitrogen was used to gauge the extent of alpha-hydroxylation during rat liver homogenate metabolism of doubly 15N-labeled N-nitrosodimethylamine (DMN) and N-nitrosomethylaniline (NMA). These measurements were correlated with the extent of total metabolism as measured by the disappearance of the nitrosamines and by the formation of formaldehyde. The results indicate that approximately 34% of DMN and 19% of NMA were metabolized by the alpha-hydroxylation pathway. Positive controls utilizing doubly 15N-labeled N-nitroso-N-methylurea yielded 96% of labeled nitrogen. These results are in variance with previously published data which claimed that either less than 5% or about 100% of DMN is metabolized by that route in vitro. Formaldehyde formation was shown to be a poor measure of the extent of metabolism. Semicarbazide gave rise to both formaldehyde and nitrogen, which makes it an undesirable component of the in vitro metabolism mixtures, particularly when those two substances are being measured.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009587 Nitrogen Isotopes Stable nitrogen atoms that have the same atomic number as the element nitrogen but differ in atomic weight. N-15 is a stable nitrogen isotope. Nitrogen Isotope,Isotope, Nitrogen,Isotopes, Nitrogen
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D004128 Dimethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents. Nitrosodimethylamine,N-Nitrosodimethylamine,NDMA Nitrosodimethylamine,N Nitrosodimethylamine,Nitrosodimethylamine, NDMA
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
December 1996, Cancer letters,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
January 1982, Carcinogenesis,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
January 1968, Voprosy onkologii,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
October 2018, Journal of agricultural and food chemistry,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
January 1983, Carcinogenesis,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
January 2011, Report on carcinogens : carcinogen profiles,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
May 1999, Farmaco (Societa chimica italiana : 1989),
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
April 1999, Cancer letters,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
January 1980, Xenobiotica; the fate of foreign compounds in biological systems,
M B Kroeger-Koepke, and S R Koepke, and G A McClusky, and P N Magee, and C J Michejda
December 1981, Analytical chemistry,
Copied contents to your clipboard!